189 related articles for article (PubMed ID: 23436584)
41. Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab.
Montal R; Oliva M; Taberna M; De Avila L; Rovira A; Cos M; Mañós M; Navarro V; Nogués J; Lozano A; Rodríguez L; Vilajosana E; Vázquez S; Mesia R
Clin Transl Oncol; 2016 Nov; 18(11):1140-1146. PubMed ID: 26960559
[TBL] [Abstract][Full Text] [Related]
42. Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
Sjövall J; Chua B; Pryor D; Burmeister E; Foote MC; Panizza B; Burmeister BH; Porceddu SV
Oral Oncol; 2015 Mar; 51(3):260-6. PubMed ID: 25553622
[TBL] [Abstract][Full Text] [Related]
43. Lessons from a standardized program using PET-CT to avoid neck dissection after primary radiotherapy for N2 squamous cell carcinoma of the oropharynx.
Hitchcock KE; Amdur RJ; Mendenhall WM; Werning JW; Drane WE; Mancuso AA
Oral Oncol; 2015 Sep; 51(9):870-4. PubMed ID: 26164415
[TBL] [Abstract][Full Text] [Related]
44. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
[TBL] [Abstract][Full Text] [Related]
45. Posttreatment surveillance PET/CT for HPV-associated oropharyngeal cancer.
Corpman DW; Masroor F; Carpenter DM; Nayak S; Gurushanthaiah D; Wang KH
Head Neck; 2019 Feb; 41(2):456-462. PubMed ID: 30549345
[TBL] [Abstract][Full Text] [Related]
46. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273
[TBL] [Abstract][Full Text] [Related]
47. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Rabalais AG; Walvekar R; Nuss D; McWhorter A; Wood C; Fields R; Mercante DE; Pou AM
Laryngoscope; 2009 Jun; 119(6):1120-4. PubMed ID: 19358193
[TBL] [Abstract][Full Text] [Related]
48. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
[TBL] [Abstract][Full Text] [Related]
49. Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer.
Kovács AF; Döbert N; Gaa J; Menzel C; Bitter K
J Clin Oncol; 2004 Oct; 22(19):3973-80. PubMed ID: 15459220
[TBL] [Abstract][Full Text] [Related]
50. Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma.
Jouhi L; Atula T; Saarilahti K; Hagström J; Haglund C; Mohamed H; Mäkitie A; Keski-Säntti H
Head Neck; 2017 Jul; 39(7):1412-1420. PubMed ID: 28464452
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
52. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
Taghipour M; Mena E; Kruse MJ; Sheikhbahaei S; Subramaniam RM
Nucl Med Commun; 2017 Mar; 38(3):250-258. PubMed ID: 28099264
[TBL] [Abstract][Full Text] [Related]
53. Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.
Bhattasali O; Han J; Thompson LDR; Buchschacher GL; Abdalla IA; Iganej S
Oral Oncol; 2018 Mar; 78():151-155. PubMed ID: 29496043
[TBL] [Abstract][Full Text] [Related]
54. Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment.
Spector ME; Chinn SB; Bellile E; Gallagher KK; Kang SY; Moyer JS; Prince ME; Wolf GT; Bradford CR; McHugh JB; Carey TE; Worden FP; Eisbruch A; Ibrahim M; Chepeha DB
JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):313-8. PubMed ID: 26892642
[TBL] [Abstract][Full Text] [Related]
55. Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
Nishimura G; Yabuki K; Hata M; Komatsu M; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
Int J Clin Oncol; 2016 Aug; 21(4):658-667. PubMed ID: 26710795
[TBL] [Abstract][Full Text] [Related]
56.
Subramaniam RM; DeMora L; Yao M; Yom SS; Gillison M; Caudell JJ; Waldron J; Xia P; Chung CH; Truong MT; Echevarria M; Chan JW; Geiger JL; Mell L; Seaward S; Thorstad WL; Beitler JJ; Sultanem K; Blakaj D; Le QT
J Nucl Med; 2023 Mar; 64(3):362-367. PubMed ID: 36215572
[TBL] [Abstract][Full Text] [Related]
57. Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.
Roskies M; Kay-Rivest E; Mascarella MA; Sultanem K; Mlynarek A; Hier M
J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):50. PubMed ID: 27724969
[TBL] [Abstract][Full Text] [Related]
58. Treatment response in the neck: p16+ versus p16- oropharyngeal cancer.
Mak D; Hicks RJ; Rischin D; Solomon B; Peters L; Bressel M; Young RJ; Corry J
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):364-72. PubMed ID: 23721148
[TBL] [Abstract][Full Text] [Related]
59. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
Chen AY; Vilaseca I; Hudgins PA; Schuster D; Halkar R
Head Neck; 2006 Jun; 28(6):487-95. PubMed ID: 16619274
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
